Clinical Trials on ADD

Total 412754 results

Tianjin Medical University Cancer Institute and...

Completed

Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLC

Non Small Cell Lung Cancer

China
Ethicon Endo-Surgery

Completed

Powered Echelon Device in VATS Surgery

Non-small Cell Lung Cancer (NSCLC)

United States
Hellenic Oncology Research Group
University Hospital of Crete

Terminated

Study of Docetaxel/Gemcitabine Followed by Chemo-radiotherapy (Chemo-RT), With or Without Consolidation Chemotherapy, in IIIA/IIIB Non Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

Greece
AstraZeneca

Completed

Epidemiological Study to Describe Non Small Cell Lung Cancer (NSCLC) Clinical Management Patterns in Central Eastern Europe and Russia (Lung-EPICLIN) (EPICLIN)

Non Small Cell Lung Cancer

Russian Federation
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

Trial of Poor Performance Status Patients (ToPPS) (ToPPS)

Non Small Cell Lung Cancer

United States
Universitaire Ziekenhuizen KU Leuven

Unknown

Whole Body Diffusion MRI for Non-invasive Lesion Detection and Therapy Follow-up: Study With Patients With Gastro-intestinal Tumors (s51240)

Non-invasive | Gastro-intestinal Tumor | Accurate Staging | Whole-body Diffusion Weighted MRI

Belgium
M.D. Anderson Cancer Center

Completed

Clofarabine in Chronic Lymphocytic Leukemia

Lymphoproliferative Disorders | Leukemia | Hematologic Neoplasms | Leukemia, Lymphocytic, Chronic

United States
Hunan Province Tumor Hospital

Unknown

Endostar Continued Pumping Into Vein Combining With Gemcitabine-Carboplatin to Treat Non-Small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

China
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Withdrawn

Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer
Peking University

Unknown

Early Palliative Care in Metastatic Esophageal Squamous Carcinoma (ESCC) and Gastric Cancer

Gastric Cancer | Metastatic Esophageal Squamous Carcinoma

China
UMC Utrecht

Unknown

MRI Optimization Study in Stage III NSCLC

Stage III Non-small Cell Lung Cancer

Netherlands
Ass. Prof. Jan Nyman
Karolinska Institutet; Göteborg University

Unknown

Stereotactic Precision And Conventional Radiotherapy Evaluation (SPACE)

Non-small Cell Lung Cancer
University of Athens

Completed

Phase IV Study of Tarceva in Patients With Advanced Stage IIIB/ IV Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

Greece
Cancer Research and Biostatistics Clinical Trials...
Novartis Pharmaceuticals; University of Arizona; Providence Cancer Center, Earle...

Completed

Study of Everolimus, Pemetrexed, Carboplatin, and Bevacizumab to Treat Stage IV Lung Cancer

Non Small Cell Lung Cancer

United States
Dong-A University Hospital
Samsung Medical Center; Asan Medical Center; Chonnam National University Hospital and other collaborators

Completed

Oxaliplatin and Prednisolone (Ox-P) for Patients With Relapsed or Refractory Marginal Zone B-cell Lymphoma(MZL)

B-cell Lymphomas

Korea, Republic of
Hellenic Oncology Research Group

Completed

Bevacizumab Plus Chemotherapy for Advanced Non Small Cell Lung Cancer Patients as 1st Line Treatment

Non Small Cell Lung Cancer

Greece
University Hospital, Bordeaux

Completed

Assessment of 4D 18F-FDG PET-CT in Radiotherapy for Non Small Cell Lung Cancers (PULMOTEP)

Lung Cancer | Non-small-cell Lung Carcinoma

France
Boehringer Ingelheim

Completed

Evaluation of the Antiviral Pharmacodynamic Effect, Safety, and Pharmacokinetics of Escalating Doses of BILB 1941 ZW to Patients With Chronic Hepatitis C Genotype 1 Virus Infection

Hepatitis C, Chronic
Centre hospitalier de l'Université de Montréal...
Centre de Recherche du Centre Hospitalier de l'Université de Montréal

Completed

Pre-Operative Assessment of Chest Wall Invasion in NSCLC Using Pre-Operative, Surgeon Performed Ultrasound (CT0010)

Non Small Cell Lung Cancer

Canada
Tongji University

Unknown

Individualized Chemotherapy Based on BRCA1 and RRM1 mRNA for Advanced Non-small Cell Lung Cancer (NSCLC) (BRAVO)

Non-small Cell Lung Cancer

China
The Netherlands Cancer Institute
International Atomic Energy Agency

Unknown

An International Study on the Use of PET/CT in Radiotherapy Planning in Low and Middle Income Countries (PERTAIN)

Non Small Cell Lung Cancer Stage III
Duke University
Eli Lilly and Company

Terminated

Study Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stage IIIB/IV Non-Small Cell Lung Cancer (TOP0602)

Non Small Cell Lung Cancer

United States
Seoul National University Hospital
Asan Medical Center; Ulsan University Hospital; Inje University; Severance Hospital

Unknown

Study of Busulfan, Etoposide, Cytarabine, and Melphalan (BuEAM) Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat B Cell Lymphoma Except for Diffuse Large B Cell Lymphoma

Non-Hodgkin Lymphoma

Korea, Republic of
Betta Pharmaceuticals Co., Ltd.

Unknown

Icotinib With Concurrent Radiotherapy Versus Chemotherapy With Concurrent Radiotherapy in Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
Novartis Pharmaceuticals

Terminated

Disease Control and Safety in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) Switching From Natalizumab to Fingolimod (TOFIINGO)

Relapsing Remitting Multiple Sclerosis (RRMS)

Germany, Spain, Australia, Israel, Switzerland, Italy, Austria, Greece, Hungary, Czech Republic, Finland
Beijing Chao Yang Hospital

Unknown

Study of Changes of Lymphocyte Subsets in Chemotherapy Course of Patients With Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer

China
Merck KGaA, Darmstadt, Germany
Smerud Medical Research International AS; Merck Serono Norway

Completed

A Scandinavian Non-interventional Study of Adherence to RebiSmart Administered Rebif New Formulation (RNF) Treatment in Relapsing Remitting Multiple Sclerosis (RRMS) Subjects (SCANSMART)

Relapsing Remitting Multiple Sclerosis (RRMS)

Norway
Pharmacyclics LLC.

Terminated

Study of Motexafin Gadolinium (MGd) in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
The Lymphoma Academic Research Organisation

Completed

A Study of Escalating Doses of Romidepsin in Association With CHOP in the Treatment of Peripheral T-Cell Lymphomas (Ro-CHOP)

Peripheral T Cell Lymphoma

France
Xencor, Inc.

Completed

Safety Study of XmAb®2513 to Treat Hodgkin Lymphoma or Anaplastic Large Cell Lymphoma

Hodgkin Lymphoma | Anaplastic Large Cell Lymphoma

United States
University of Chicago
Bristol-Myers Squibb

Terminated

Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

United States
Genentech, Inc.

Completed

A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Lung Cancer | Non-small-cell Lung Carcinoma

United States
University Hospital, Angers

Unknown

Identification by Microarrays of the Risks of Metastatic Relapse, Toxicity and Resistance to Adjuvant Chemotherapy in Completely Resected Non-small Cell Lung Cancer (SITRR)

Non-small Cell Lung Cancer

France
GlaxoSmithKline

Completed

SCOT Registry: Small Cell Lung Cancer Treatment and Outcome (SCOT)

Lung Cancer, Small Cell

Spain, France, Netherlands, Korea, Republic of, Greece, Slovenia, Italy, Czech Republic, Germany, Austria, Hungary, Poland, Estonia, Lithuania
National University Hospital, Singapore

Unknown

A Study of Predictive and Prognostic Markers in Patients With Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

Singapore
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific
Zhejiang University

Unknown

Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Lung Cancer

Non Small Cell Lung Cancer

China
Michael Mann
Sanofi

Completed

Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer

Non-small Cell Lung Cancer

United States, China
National University Hospital, Singapore

Unknown

A Retrospective Study of Biomarkers in Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer

Singapore
National University Hospital, Singapore
Massachusetts General Hospital; AstraZeneca

Unknown

Hydroxychloroquine and Gefitinib to Treat Lung Cancer

Non-small Cell Lung Cancer

Singapore
Genzyme, a Sanofi Company

Completed

A Study to Confirm the Efficacy and Safety of Fludarabine Phosphate Administered in Untreated Chronic Lymphocytic Leukemia Patients With Anemia and/or Thrombocytopenia

Leukemia, Lymphocytic, Chronic, B-Cell
Eisai Inc.

Withdrawn

A Phase 3 Trial of E7777 in Combination With CHOP Compared With CHOP Alone for the First-Line Treatment of Peripheral T-cell Lymphoma

Peripheral T-Cell Lymphoma

United States
Pfizer

Completed

A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.

Adenocarcinoma | Non-Small-Cell Lung Carcinoma

United States, Spain, Poland, Czech Republic, United Kingdom, France
Third Military Medical University

Unknown

Gossypol Combined With Docetaxel and Cisplatin Scheme in Advanced Non Small-cell Lung Cancers With APE1 High Expression (GTCA)

Non-small Cell Lung Cancer

China
Eli Lilly and Company

Completed

A Study in Non-squamous Non Small Cell Lung Cancer in Asian Patients

Non Small Cell Lung Cancer

Japan
Ruhr University of Bochum

Unknown

Two Measures of Tactile Acuity in CRPS Type I Patients

Healthy Controls | CRPS Type I of the Upper Extremity | Neuropathy of the Median Nerve

Germany
Schillerhoehe Hospital

Completed

Early Detection of Lung Tumors by Sniffer Dogs - Evaluation of Sensitivity and Specificity

Lung Cancer | Chronic Obstructive Airway Disease

Germany
Accuray Incorporated
Centre Oscar Lambret

Terminated

CyberKnife® for Hepatic Metastases From Colorectal Cancer

Colorectal Liver Metastases

France, Germany, United Kingdom
Cell>Point LLC
Venn Life Sciences; Numoda; Camargo Pharmaceutical Services; Biomedical Services

Completed

Phase 2 Study Comparing 99mTc-EC-DG SPECT/CT With 18F FDG PET/CT in Patients With Non-small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

United States, Canada
Cell>Point LLC
Venn Life Sciences; Biomedical Systems; Numoda; Camargo Pharmaceutical Services

Completed

Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

United States

Clinical Trials on ADD

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations